Full Content is available to subscribers Subscribe/Learn More Original Investigation | ONLINE FIRST Perioperative Use of Selective Serotonin Reuptake Inhibitors and Risks for Adverse Outcomes of Surgery Andrew D. Auerbach, MD, MPH; Eric Vittinghoff, PhD; Judith Maselli, MSPH; Penelope S. Pekow, PhD; John Q. Young, MD; Peter K. Lindenauer, MD, MS JAMA Intern Med. 2013;():1-7. […]

Vulnerabilities to misinformation in online pharmaceutical marketing   Julian De Freitas1 Brian A Falls2 Omar S Haque3 Harold J Bursztajn4? 1Department of Psychology, Yale University, New Haven, CT 06520, USA 2Department of Psychiatry, Harvard Medical School, VA Boston Healthcare System, Boston, MA 02169, USA 3Program in Psychiatry and the Law, Harvard Medical School, Boston, MA […]

Review article Late-life depression and risk of vascular dementia and Alzheimer?s disease: systematic review and meta-analysis of community-based cohort studies Breno S. Diniz, Meryl A. Butters, Steven M. Albert, Mary Amanda Dew and Charles F. Reynolds 3rd + Author Affiliations Breno S. Diniz, MD, PhD, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, […]

Interesting applied psychoimmunology study. Apparently depressed people’s guts don’t watch direct-to-consumer chemical-imbalance ads. Here is the abstract. Depression, antidepressant medications, and risk of Clostridium difficile infection Mary A M Rogers1*, M Todd Greene1, Vincent B Young1, Sanjay Saint1,2, Kenneth M Langa1,2, John Y Kao1 and David M Aronoff1 * Corresponding author: Mary A M Rogers […]

Went to a masterful talk by E. Sander Connolly at the Lenox Hill Hospital neurology conference last week. This is one of many interesting take-away points. Differential blood-brain barrier penetration by the various statins is another one – currently looking into how this impacts clinical decision making. MP J Neurosurg. Author manuscript; available in PMC […]